Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Endocr Metab Immune Disord Drug Targets ; 21(10): 1775-1780, 2021.
Article in English | MEDLINE | ID: covidwho-1562450

ABSTRACT

In late 2019, SARS-COV-2 disease was firstly discovered in Wuhan, China and then it infected millions of people worldwide. Later, the World Health Organization (WHO) described COVID-19 as the first pandemic invading the world in the 21st century. The WHO has declared that the emerging infection will last long enough to force adjustments not only in people's lifestyles but also in the health care system. This amendment is expected to spread through many medical practices and specialties. A lot of diagnostic and therapeutic modalities have been proposed for COVID-19 management. The best strategy for the management of patients requires a multi-disciplinary team approach with correct decisions regarding the right timing of each modality of treatment. The participating multidisciplinary team for COVID-19 management includes six infectious diseases experts in Tanta University; one critical care management expert, an emergency medicine expert and two pharmacists in Tanta University. In this review, we reported our multi-disciplinary team experience with up to date literature guidance to propose a valid protocol for the management of COVID-19 patients in a limited resources setting.


Subject(s)
Academic Medical Centers/methods , COVID-19/prevention & control , Developing Countries , Disease Management , Health Resources , Patient Care Team , Academic Medical Centers/economics , COVID-19/economics , COVID-19/epidemiology , Developing Countries/economics , Egypt/epidemiology , Health Resources/economics , Humans , Patient Care Team/economics
2.
Muscle Nerve ; 64(3): 361-364, 2021 09.
Article in English | MEDLINE | ID: covidwho-1363719

ABSTRACT

INTRODUCTION/AIMS: The initial surge of the coronavirus disease-2019 (COVID-19) pandemic in early 2020 led to widespread cancellation of elective medical procedures in the United States, including nonurgent outpatient and inpatient electrodiagnostic (EDx) studies. As certain regions later showed a downtrend in daily new cases, EDx laboratories have reopened under the guidance of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM). In our reopening experience guided by the AANEM, we measured relevant outcomes to determine further workflow adaptations. We aimed to detail our experience and share the lessons learned. METHODS: We reviewed the clinical volumes, billing data, diagnosis distributions, and rates of COVID-19 exposure and transmission among patients and staff in our EDx laboratory during the first 6 months of reopening, starting on June 1, 2020. For context, we detailed the recent AANEM guidelines we adopted at our laboratory, supplemented by other consensus statements. RESULTS: We completed 816 outpatient studies from June 1 to December 1, 2020, reaching 97% of the total volume and 97% of total billing compared with the same time period in 2019. The average relative value units per study were similar. There were no major shifts in diagnosis distributions. We completed 10 of 12 requested inpatient studies during this period. There were no known COVID-19 transmissions between patients and staff. DISCUSSION: Our experience suggests that it is possible to safely operate an EDx laboratory under the guidance of the AANEM and other experts, with clinical volume and billing rates comparable to pre-pandemic baselines.


Subject(s)
Academic Medical Centers/standards , COVID-19/prevention & control , Electrodiagnosis/standards , Neural Conduction/physiology , Workflow , Academic Medical Centers/methods , Academic Medical Centers/trends , COVID-19/epidemiology , Electrodiagnosis/methods , Electrodiagnosis/trends , Humans , Time Factors
3.
Acad Med ; 96(7): 1005-1009, 2021 07 01.
Article in English | MEDLINE | ID: covidwho-1165513

ABSTRACT

PROBLEM: The COVID-19 pandemic has challenged health care systems in an unprecedented way by imposing new demands on health care resources and scientific knowledge. There has also been an exceedingly fast accumulation of new information on this novel virus. As the traditional peer-review process takes time, there is currently a significant gap between the ability to generate new data and the ability to critically evaluate them. This problem of an excess of mixed-quality data, or infodemic, is echoing throughout the scientific community. APPROACH: The authors aimed to help their colleagues at the Rambam Medical Center, Haifa, Israel, manage the COVID-19 infodemic with a methodologic solution: establishing an in-house mechanism for continuous literature review and knowledge distribution (March-April 2020). Their methodology included the following building blocks: a dedicated literature review team, artificial intelligence-based research algorithms, brief written updates in a graphical format, large-scale webinars and online meetings, and a feedback loop. OUTCOMES: During the first month (April 2020), the project produced 21 graphical updates. After consideration of feedback from colleagues and final editing, 13 graphical updates were uploaded to the center's website; of these, 31% addressed the clinical presentation of the disease and 38% referred to specific treatments. This methodology as well as the graphical updates it generated were adopted by the Israeli Ministry of Health and distributed in a hospital preparation kit. NEXT STEPS: The authors believe they have established a novel methodology that can assist in the battle against COVID-19 by making high-quality scientific data more accessible to clinicians. In the future, they expect this methodology to create a favorable uniform standard for evidence-guided health care during infodemics. Further evolution of the methodology may include evaluation of its long-term sustainability and impact on the day-to-day clinical practice and self-confidence of clinicians who treat COVID-19 patients.


Subject(s)
Academic Medical Centers , Biomedical Research , COVID-19 , Evidence-Based Practice/methods , Information Dissemination/methods , Information Services , Review Literature as Topic , Academic Medical Centers/methods , Academic Medical Centers/organization & administration , Artificial Intelligence , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19/therapy , Disease Outbreaks , Evidence-Based Practice/organization & administration , Humans , Information Services/organization & administration , Israel/epidemiology , Peer Review, Research
4.
World Neurosurg ; 151: e68-e77, 2021 07.
Article in English | MEDLINE | ID: covidwho-1164602

ABSTRACT

BACKGROUND: Medical subspecialties including neurosurgery have seen a dramatic shift in operative volume in the wake of the coronavirus disease 2019 (COVID-19) pandemic. The goal of this study was to quantify the effects of the COVID-19 pandemic on operative volume at 2 academic neurosurgery centers in New Orleans, Louisiana, USA from equivalent periods before and during the COVID-19 pandemic. METHODS: A retrospective review was conducted analyzing neurosurgical case records for 2 tertiary academic centers from March to June 2020 and March to June 2019. The records were reviewed for variables including institution and physician coverage, operative volume by month and year, cases per subspecialty, patient demographics, mortality, and morbidity. RESULTS: Comparison of groups showed a 34% reduction in monthly neurosurgical volume per institution during the pandemic compared with earlier time points, including a 77% decrease during April 2020. There was no change in mortality and morbidity across institutions during the pandemic. CONCLUSIONS: The COVID-19 pandemic has had a significant impact on neurosurgical practice and will likely continue to have long-term effects on patients at a time when global gross domestic products decrease and relative health expenditures increase. Clinicians must anticipate and actively prepare for these impacts in the future.


Subject(s)
Academic Medical Centers/trends , COVID-19/epidemiology , Internship and Residency/trends , Neurosurgical Procedures/education , Neurosurgical Procedures/trends , Time-to-Treatment/trends , Academic Medical Centers/methods , Adult , Aged , COVID-19/prevention & control , Female , Humans , Internship and Residency/methods , Length of Stay/trends , Male , Middle Aged , Neurosurgery/education , Neurosurgery/methods , Neurosurgery/trends , Neurosurgical Procedures/methods , New Orleans/epidemiology , Pandemics/prevention & control , Retrospective Studies
5.
Int J Pediatr Otorhinolaryngol ; 139: 110447, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-882582

ABSTRACT

OBJECTIVE: To describe the implementation of telemedicine in a pediatric otolaryngology practice during the coronavirus disease 2019 (COVID-19) global pandemic. METHODS: A descriptive paper documenting the development and application of telemedicine in a tertiary academic pediatric otolaryngology practice. RESULTS: A total of 51 established patients were seen via telemedicine within the first 2 weeks of telemedicine implementation. Seven (7) patients were no shows to the appointment. The median patient age was 5 years old, with 55% male patients. Common diagnoses for the visits included sleep disordered breathing/obstructive sleep apnea (25%) and hearing loss (19.64%). Over half (50.98%) of visits were billed at level 4 visit code. DISCUSSION: The majority (88%) of visits during the first 2 weeks of telemedicine implementation in our practice were completed successfully. Reasons that patients did not schedule telemedicine appointments included preference for in person appointments, and lack of adequate device at home to complete telemedicine visit. Limitations to our telemedicine practice included offering telemedicine only to patients who had home internet service, were established patients, and English-speaking. Trainees were not involved in this initial implementation of telemedicine. CONCLUSIONS: COVID-19 has driven the rapid adoption of telemedicine in outpatient medicine. Our group was able to institute an effective telemedicine practice during this time.


Subject(s)
Academic Medical Centers/organization & administration , COVID-19/prevention & control , Health Services Accessibility/organization & administration , Infection Control/organization & administration , Otolaryngology/organization & administration , Pediatrics/organization & administration , Telemedicine/organization & administration , Academic Medical Centers/methods , COVID-19/epidemiology , Child , Child, Preschool , Female , Georgia/epidemiology , Humans , Infection Control/methods , Male , Otolaryngology/methods , Pandemics , Pediatrics/methods , Telemedicine/methods
6.
Perspect Med Educ ; 10(2): 135-140, 2021 03.
Article in English | MEDLINE | ID: covidwho-848555

ABSTRACT

BACKGROUND: As cases of COVID-19 climb worldwide, academic medical centers (AMCs) are scrambling to balance the increasing demand for medical services while maintaining safe learning environments. The scale and nature of the current pandemic, limitations on key resources, risks of transmission, and the impact on trainee wellbeing pose additional challenges to AMCs. We propose a framework for AMCs to utilize in facilitating health system, organization and program-level adjustments to meet the needs of medical trainees during the pandemic. APPROACH: In February 2020, we developed a three-level approach to the pandemic response of training programs at our AMC. The first level involved AMC alignment and engagement with regulatory stakeholders. The second level utilized the graduate medical education committee and leveraged organizational functions such as human resources, finance, and clinical departments. The third level of intervention focused on common approaches used by programs to ensure continuity of learning in the context of dynamic changes in workflows and service operations. EVALUATION: Outcomes at each level are reported. These include the co-development of a national framework on medical trainee responses to COVID-19, the composition of an operational guidance document, organizational protocols to accommodate novel challenges posed by the pandemic, and multiple program-level interventions. REFLECTION: This methodical approach, employed during a global crisis, was critical in facilitating interventions required to fulfill the mission of AMCs. Future steps include assessing the impact of these changes on trainee performance and the applicability of the approach in diverse settings.


Subject(s)
Academic Medical Centers/methods , COVID-19 , Education, Medical, Graduate/methods , Internship and Residency/methods , Humans , SARS-CoV-2 , Stakeholder Participation , United Arab Emirates
7.
Clin Neuropsychol ; 34(7-8): 1352-1366, 2020.
Article in English | MEDLINE | ID: covidwho-651984

ABSTRACT

Objectives: Emory University has modified its clinical practices across specialties in response to the 2020 COVID-19 pandemic to provide service delivery while maintaining patient, staff, and faculty safety. This report shares current solutions and workarounds associated with telehealth neuropsychology (teleNP) while also recognizing teleNP opportunities.Results: We modified many measures from our traditional assessment protocols so they could be administered through Zoom. To maximize quality control, formal how-to coversheets and manuals were developed for both training and task administration (i.e. navigating Zoom assessment interfaces, practicing adapted test instructions, and troubleshooting).Conclusions: TeleNP has been successfully used to answer referral questions regarding deep brain stimulation (DBS) candidacy in Parkinson's disease patients and presence of mild neurocognitive impairment in patients with subjective memory decline. Our current protocols will continue to evolve with greater experience and are not considered to be a finished product. Nevertheless, development of robust teleNP protocols should expand availability of neuropsychology in both clinical and research applications while simultaneously decreasing assessment burden associated with traveling - sometimes long distances - for diagnostic neuropsychological evaluation.


Subject(s)
Academic Medical Centers/trends , Betacoronavirus , Coronavirus Infections/therapy , Neuropsychology/trends , Pandemics , Pneumonia, Viral/therapy , Telemedicine/trends , Academic Medical Centers/methods , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/psychology , Humans , Neuropsychological Tests , Neuropsychology/methods , Pneumonia, Viral/epidemiology , Pneumonia, Viral/psychology , Program Development/methods , SARS-CoV-2 , Telemedicine/methods
9.
World Neurosurg ; 139: e877-e884, 2020 07.
Article in English | MEDLINE | ID: covidwho-343579

ABSTRACT

OBJECTIVE: Coronavirus disease 2019 (COVID-19) is a disruptive pandemic that has continued to test the limits of health care system capacities. It is important to highlight the specific challenges facing US neurosurgery during these difficult circumstances. In the present study, we have described our neurosurgery department's unique experience during the COVID-19 pandemic. METHODS: We analyzed the following data points both before and during the first months of the COVID-19 pandemic: the number of patients infected with COVID-19 at our institution, changes in neurosurgical operative workflow, changes in neurosurgical outpatient and inpatient clinic workflows, resident redeployment statistics and changes in call schedules, and changes in neurosurgical education. RESULTS: At our institution, the adult surgery numbers decreased from 120 during the week of March 4-11, 2020 (before the World Health Organization had classified the COVID-19 outbreak as a pandemic) to 17 during the week of April 13-17, 2020. The number of pediatric surgeries decreased from 15 to 3 during the same period. Significantly more surgeries were cancelled than were delayed (P < 0.0001). A drastic decline occurred in the number of in-person neurosurgery clinic visits (97.12%) between March and April 2020 (P = 0.0020). The inpatient census declined from mid-March to mid-April 2020 by 44.68% compared with a 4.26% decline during the same period in 2019 (P < 0.0001). Finally, neurosurgery education has largely shifted toward video-conferencing sessions rather than in-person sessions. CONCLUSION: By detailing our experience during the COVID-19 pandemic, we hope to have provided a detailed picture of the challenges facing neurosurgery within an academic medical center.


Subject(s)
Academic Medical Centers/trends , Betacoronavirus , Coronavirus Infections/surgery , Neurosurgery/trends , Neurosurgical Procedures/trends , Pneumonia, Viral/surgery , Academic Medical Centers/methods , Adult , Ambulatory Care/methods , Ambulatory Care/trends , COVID-19 , Child , Coronavirus Infections/epidemiology , Female , Humans , Male , Neurosurgery/methods , Neurosurgical Procedures/methods , Pandemics , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Workflow
10.
J Neurointerv Surg ; 12(7): 654-657, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-223372

ABSTRACT

BACKGROUND: Enrollment in time-sensitive endovascular stroke trials can be challenging because of an inability to consent a debilitated patient. Often the legally authorized representative is not on site. Remote consent procedures in the US are inconsistent with the majority of sites shunning these approaches. The current pandemic with visitor restrictions highlights the need for enhancing these options. METHODS: Remote electronic and phone consent procedures specifically for endovascular stroke trials from two comprehensive stroke centers (CSC) are presented. An overview of the genesis of informed consent procedures in the US is also included. RESULTS: The two CSCs identified as Institution-1 and Institution-2 are large tertiary systems. Institution-1 is a non-profit university-affiliated academic medical center in rural geography. Institution-2 is an HCA hospital in an urban environment. Both serve patients through a spoke-and-hub network, have participated in multiple randomized endovascular stroke trials, and have successfully used these remote options for enrollment. A tiered approach is employed at both institutions with an emphasis on obtaining informed consent in person and resorting to alternatives methods when efforts to that are unsuccessful. A rationale for electronic and phone consent is included, followed by step-by-step illustration of the process at each institution. CONCLUSION: Two examples of remote electronic or phone consent procedures from institutions in different geographic environments and organization structures demonstrate that these options can be successfully used for enrollment in stroke trials. The current pandemic highlights the need to enhance these approaches while maintaining appropriate adherence to ethical and legal frameworks.


Subject(s)
Betacoronavirus , Clinical Trials as Topic/methods , Coronavirus Infections/epidemiology , Informed Consent , Pneumonia, Viral/epidemiology , Stroke/epidemiology , Telemedicine/methods , Academic Medical Centers/methods , COVID-19 , Cell Phone , Coronavirus Infections/diagnosis , Coronavirus Infections/therapy , Humans , Pandemics , Patient Selection , Pneumonia, Viral/diagnosis , Pneumonia, Viral/therapy , SARS-CoV-2 , Stroke/diagnosis , Stroke/therapy
SELECTION OF CITATIONS
SEARCH DETAIL